.avif)
Juniper is a deep tech venture capital firm investing in biotechnology—just not the kind you’re thinking of.
.webp)
Our Why
We invest in biology at the frontier of new industries.
Engineered biology is transforming life from something we study into something we build, unlocking markets, industries, and ways of inventing the future.
Today, visionary founders are building ecosystems, capabilities, and applications across manufacturing, mining, food, agriculture, conservation, and more. We partner with entrepreneurs to build an optimistic future empowered by programmable biology—pioneers creating new categories and disruptors upgrading the means of production.
When cutting-edge technologies meet trillion-dollar opportunities, they generate unparalleled impact and returns. The bioindustrial revolution is here.
Our Thesis
Technical founders need technically fluent investors who support them at the earliest stages of company formation.
They need early believers and champions capable of catalyzing their critical first round of funding and beyond. That’s us.
We champion the vision of pioneering founders and work closely with other early stage investors to share our technical expertise, while creating coalitions of investors building momentum into new industries.
.webp)
The Juniper genus is one of the most diverse and hardy in nature. The trees thrive in an extremely wide range of habitats, are amazingly resilient, and are renowned for their longevity. Here at Juniper, our life’s work is to support founders as they grow world-changing companies that are built to last.
Why Juniper
Our Team
Jenny is a bioengineer, entrepreneur, and investor partnering with founders advancing the frontiers of biology. She holds a PhD from the University of Cambridge and previously led enzyme engineering projects at Caltech that were highlighted in the 2018 Nobel Prize lecture in Chemistry. A recognized expert in synthetic biology, Jenny brings deep technical insight and pattern recognition to early-stage investing. She has backed over 50 deep tech startups reimagining how we make, move, and sustain the physical world, and was named by Forbes as a leading venture capitalist shaping the future of the field.
Michael is a founder and early-stage climate investor focused on building scalable, mission-driven ventures. He began his career in Washington as a policymaker before founding The Tuesday Company, a political tech startup acquired by Bloomberg Philanthropies. He later co-founded the Climate Capital Syndicate, now one of the most active early-stage climate investment groups globally, with over 100 portfolio companies. Michael believes that transformative change stems from entrepreneurial ventures that scale sustainable, abundant futures.
Mackenzie is a biologist focused on cultivating communities where innovation and collaboration thrive. As a graduate student, she helped launch and expand Nucleate Eco’s Activator program, which supports academic scientists in translating research into biotech startups. Earlier in her career, she lobbied for climate legislation with the American Forest Foundation, where she saw how relationship-building drives meaningful change. Mackenzie is also the co-founder of Planet Jam, a cornerstone event series within the LA climate ecosystem. She holds a B.A. from Dartmouth College and an MSc in Evolutionary Biology from UCLA.
Enabling the next wave of category creators building transformative technologies.
